Gerald M. Lieberman

This profile gathers the share dealings of Gerald M. Lieberman across 5 companies, led by Entera Bio Ltd., Teva Pharmaceutical Industries Ltd and Alliancebernstein Holding L.P. In total, 39 filings cover trades dated from 3 February 2006 to 1 January 2026.

On the market, this insider has only ever bought: 12 purchases, €93k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 10 share grants and 11 option exercises.

A typical purchase (the median) is worth €2,169. On 9 out of 9 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 2 January 2026 with a share grant in Entera Bio Ltd. The most recent open-market purchase was published on 27 December 2023, 1,032 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.